General Information of the Compound
Compound ID
CP0144481
Compound Name
1-(2-(benzo[d]isoxazol-3-yl)ethyl)-N-(4-chlorophenyl)-1H-pyrazole-5-carboxamide
    Show/Hide
Structure
Formula
C19H15ClN4O2
Molecular Weight
366.808
Canonical SMILES
Clc1ccc(NC(=O)c2ccnn2CCc2noc3ccccc23)cc1
    Show/Hide
InChI
InChI=1S/C19H15ClN4O2/c20-13-5-7-14(8-6-13)22-19(25)17-9-11-21-24(17)12-10-16-15-3-1-2-4-18(15)26-23-16/h1-9,11H,10,12H2,(H,22,25)
    Show/Hide
InChIKey
JNVJONNEWQUJDS-UHFFFAOYSA-N
Physicochemical Property
logP
4.1727
Rotatable Bonds
5
Heavy Atom Count
26
Polar Areas
72.95
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44431895
ChEMBL ID
CHEMBL237679
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00864, Vascular endothelial growth factor receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS